Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs JPMorgan Nasdaq Equity Premium Income ETF (JEPQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs JPMorgan Nasdaq Equity Premium Income ETF — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.38 (market cap $4.03B), while JPMorgan Nasdaq Equity Premium Income ETF trades at $59.73 (market cap $43.97B). The key difference: JPMorgan Nasdaq Equity Premium Income ETF is far larger — about 10.9× Indivior Pharmaceuticals Inc. Common Stock's market cap, and JPMorgan Nasdaq Equity Premium Income ETF is trading nearer its 52-week high, Indivior Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and JPMorgan Nasdaq Equity Premium Income ETF for 67 Days on average.
| INDV | JEPQ | |
|---|---|---|
Market Cap | $4.03B | $43.97B |
Volume | 2,781,171 | 6,284,829 |
Sector | Health | Income / Options Overlay |
52-Week High | $41.83 | $61.46 |
52-Week Low | $24.09 | $53.77 |
Typical Hold Time | 0 Days | 67 Days |
Enterprise Value | $4.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JEPQ trades at $59.51, down 2.31% with bearish technical signals from moving averages. The ETF's covered-call strategy generates high monthly income, with recent dividends ranging from $0.57 to $0.70. RSI indicators suggest potential oversold conditions at 13.75 (6-day) and 27.84 (12-day), while ADX shows strong trend momentum. Support levels cluster around $59-60 with resistance at $60-61.
The ETF offers attractive income generation through its Nasdaq-focused covered-call strategy but faces headwinds from market volatility and limited price appreciation potential. Investors benefit from monthly distributions while accepting capped upside during strong bull markets. Key risks include dependence on options premiums and tech sector concentration.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About JPMorgan Nasdaq Equity Premium Income ETF
JEPQ seeks to provide monthly income and exposure to the Nasdaq-100 Index with less volatility. It uses a methodology that combines high-growth tech stocks with an options strategy to capture income.
Read more on JEPQ →
